Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients.
about
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disordersThe endocannabinoid system as an emerging target of pharmacotherapyRecreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected menThe toxicology of cannabis and cannabis prohibitionCannabinoids and Viral Infections.Therapeutic potential of cannabinoid medicines.Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virusCannabinoid neuroimmune modulation of SIV disease.Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cellsDrugs of abuse, immune modulation, and AIDS.Co-factors in HIV neurobehavioural disturbances: substance abuse, hepatitis C and aging.Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin.HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.Marijuana as therapy for people living with HIV/AIDS: Social and health aspects
P2860
Q22299116-6355CA31-0930-4D3B-8DFE-64679DE0CE31Q24648473-BA159E35-CFD9-4DF8-987D-2E251EF95985Q24650832-F5332896-CE90-4E86-A809-B98385FB4189Q28241637-C8558C23-2B87-4EC8-8CC9-A6D08B3C66AAQ33992923-B6CD4E9C-AF90-4618-B491-D69BEBB548A3Q34368715-45853720-20E3-4111-8866-2F6DC7175044Q35000656-23C786AF-C9E3-4D75-984A-017BE9B8D604Q35119113-7D35ECEA-77DE-41D9-99D1-DD993E1AA25EQ35529056-A1692166-4958-4AC3-9E67-5A92C52265CDQ35752103-4FCA13D5-9FC5-4551-BFD6-153FDA512DAEQ35842577-F289FEF8-9B0D-449A-9838-DE31BAEADEDCQ37015427-067D52D6-B072-4EE1-B5C2-99EE32CC6363Q37073662-92F98540-4811-403D-804E-9FEFD24C2DFFQ37149288-BF71B3DF-C2F5-4415-B4B2-D7C778FF0DB1Q37244823-F5FA173E-B7A2-4382-B52E-A174576BC6CCQ37919370-658EF425-5AFB-43F4-82DE-26A731ECC26FQ39213852-2D034DF6-A53D-433C-AE23-62F4BB013046Q40701297-FF10132C-214E-4738-8911-53DA6EEAA430Q42230380-29478E26-0A0F-4BF3-8C13-FE3E24E6C9E3Q58055031-BFDBDD4D-9C31-4ACC-94C1-9E541ADA7584
P2860
Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@en
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@nl
type
label
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@en
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@nl
prefLabel
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@en
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@nl
P2093
P2860
P1476
Short-term effects of cannabin ...... on in HIV-1-infected patients.
@en
P2093
Barry M Bredt
Dana Higuera-Alhino
Donald I Abrams
Joseph M McCune
Samuel J Hebert
Starley B Shade
P2860
P304
P356
10.1002/J.1552-4604.2002.TB06007.X
P433
P577
2002-11-01T00:00:00Z